Blaise S. Lippa

Person

Acton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antagonists of human integrin α4β7
- Patent number 12,221,416
- Issue date Feb 11, 2025
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of (α-v)(β-6) integrin
- Patent number 12,145,935
- Issue date Nov 19, 2024
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of (α-v)(β-6) integrin
- Patent number 11,827,621
- Issue date Nov 28, 2023
- Morphic Therapeutic, Inc.
- Mark Brewer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of (α-v)(β-6) integrin
- Patent number 11,795,167
- Issue date Oct 24, 2023
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibiting (α-v)(β-6) integrin
- Patent number 11,739,087
- Issue date Aug 29, 2023
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibiting human integrin (alpha-4) (beta-7)
- Patent number 11,370,773
- Issue date Jun 28, 2022
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonists of human integrin (α4)(β7)
- Patent number 11,174,228
- Issue date Nov 16, 2021
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting human integrin (α-4) (β-7)
- Patent number 11,104,661
- Issue date Aug 31, 2021
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of (α-v)(β-6) integrin
- Patent number 11,046,669
- Issue date Jun 29, 2021
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of (α-v)(β-6) integrin
- Patent number 11,046,685
- Issue date Jun 29, 2021
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of (alpha-v)(beta-6) integrin
- Patent number 11,040,955
- Issue date Jun 22, 2021
- Morphic Therapeutic, Inc.
- Mark Brewer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting (α-V)(β-6) integrin
- Patent number 11,021,480
- Issue date Jun 1, 2021
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonists of human integrin α4β7
- Patent number 10,759,756
- Issue date Sep 1, 2020
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting the transient receptor potential A1 ion channel
- Patent number 10,428,072
- Issue date Oct 1, 2019
- Eli Lilly and Company
- Blaise S. Lippa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting the transient receptor potential A1 ion channel
- Patent number 9,394,308
- Issue date Jul 19, 2016
- Merck Sharp & Dohme Corp.
- Qingyi Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting transient receptor potential ion channel TRPA1
- Patent number 9,193,729
- Issue date Nov 24, 2015
- Cubist Pharmaceuticals, Inc.
- Chester A. Metcalf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibiotic compositions for the treatment of gram negative infections
- Patent number 8,906,866
- Issue date Dec 9, 2014
- BioSource Pharm, Inc.
- William V. Curran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibiotic compositions for the treatment of gram negative infections
- Patent number 8,415,307
- Issue date Apr 9, 2013
- BioSource Pharm, Inc.
- William V. Curran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20250223289
- Publication date Jul 10, 2025
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20240376095
- Publication date Nov 14, 2024
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20240327378
- Publication date Oct 3, 2024
- Morphic Therapeutic, Inc.
- Mark Brewer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20240294475
- Publication date Sep 5, 2024
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING HUMAN INTEGRIN (ALPHA-4) (BETA-7)
- Publication number 20240174632
- Publication date May 30, 2024
- Morphic Therapeutic, Inc.
- Matthew G. BURSAVICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20240116929
- Publication date Apr 11, 2024
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF AV ß6 INTEGRIN
- Publication number 20230219947
- Publication date Jul 13, 2023
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20230219949
- Publication date Jul 13, 2023
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20220340529
- Publication date Oct 27, 2022
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20220073511
- Publication date Mar 10, 2022
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20210284640
- Publication date Sep 16, 2021
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20210276975
- Publication date Sep 9, 2021
- Morphic Therapeutic, Inc.
- Mark Brewer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20200385352
- Publication date Dec 10, 2020
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20200385384
- Publication date Dec 10, 2020
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20200354359
- Publication date Nov 12, 2020
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20200157075
- Publication date May 21, 2020
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20200087299
- Publication date Mar 19, 2020
- Morphic Therapeutic, Inc.
- Mark Brewer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20200071322
- Publication date Mar 5, 2020
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20200002334
- Publication date Jan 2, 2020
- Morphic Therapeutic, Inc.
- Bryce A. Harrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20190315692
- Publication date Oct 17, 2019
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN
- Publication number 20180244648
- Publication date Aug 30, 2018
- Lazuli, Inc.
- Bryce A. Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
- Publication number 20180230149
- Publication date Aug 16, 2018
- Hydra Biosciences, Inc.
- Blaise S. Lippa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 ANTAGONIST COMPOUNDS
- Publication number 20170216295
- Publication date Aug 3, 2017
- MERCK SHARP & DOHME CORP.
- Bhuamik Pandya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
- Publication number 20170050966
- Publication date Feb 23, 2017
- Hydra Biosciences, Inc.
- Blaise S. Lippa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
- Publication number 20140206650
- Publication date Jul 24, 2014
- Blaise S. Lippa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING TRPA1 FOR THE TREATMENT OF ASTHMA
- Publication number 20140158116
- Publication date Jun 12, 2014
- Cubist Pharmaceuticals, Inc.
- Jayhong A. Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibiotic Compositions for the Treatment of Gram Negative Infections
- Publication number 20140073559
- Publication date Mar 13, 2014
- Cubist Pharmaceuticals, Inc.
- William V. Curran
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Inhibiting Transient Receptor Potential Ion Channel TRPA1
- Publication number 20130274273
- Publication date Oct 17, 2013
- Cubist Pharmaceuticals, Inc.
- Chester A. Metcalf
- C07 - ORGANIC CHEMISTRY

Blaise S. Lippa

Person

Patents Grantslast 30 patents

Antagonists of human integrin α4β7

Inhibitors of (α-v)(β-6) integrin

Inhibitors of (α-v)(β-6) integrin

Inhibitors of (α-v)(β-6) integrin

Inhibiting (α-v)(β-6) integrin

Inhibiting human integrin (alpha-4) (beta-7)

Antagonists of human integrin (α4)(β7)

Inhibiting human integrin (α-4) (β-7)

Inhibitors of (α-v)(β-6) integrin

Inhibitors of (α-v)(β-6) integrin

Inhibitors of (alpha-v)(beta-6) integrin

Inhibiting (α-V)(β-6) integrin

Antagonists of human integrin α4β7

Inhibiting the transient receptor potential A1 ion channel

Inhibiting the transient receptor potential A1 ion channel

Inhibiting transient receptor potential ion channel TRPA1

Antibiotic compositions for the treatment of gram negative infections

Antibiotic compositions for the treatment of gram negative infections

Patents Applicationslast 30 patents

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

INHIBITING (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

INHIBITING HUMAN INTEGRIN (ALPHA-4) (BETA-7)

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF AV ß6 INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

INHIBITING (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

INHIBITING (ALPHA-V)(BETA-6) INTEGRIN

INHIBITING (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

INHIBITING (ALPHA-V)(BETA-6) INTEGRIN

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

CCR9 ANTAGONIST COMPOUNDS

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

INHIBITING TRPA1 FOR THE TREATMENT OF ASTHMA

Antibiotic Compositions for the Treatment of Gram Negative Infections

Inhibiting Transient Receptor Potential Ion Channel TRPA1